9fa604f7e9712e064c0f6a7067001e9c.jpg - Washington Times
Skip to content

FILE - This photo provided by Actavis shows the company's logo. Actavis PLC plans to buy Forest Laboratories Inc. in an approximately $25 billion cash-and-stock combination that will create a drugmaker with a product portfolio that includes drugs like the Alzheimer's disease treatment Namenda. (AP Photo/Actavis, File)

FILE - This photo provided by Actavis shows the company's logo. Actavis PLC plans to buy Forest Laboratories Inc. in an approximately $25 billion cash-and-stock combination that will create a drugmaker with a product portfolio that includes drugs like the Alzheimer's disease treatment Namenda. (AP Photo/Actavis, File)

Featured Photo Galleries